| Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 253 | 2021 |
| A two years open-label prospective study of OnabotulinumtoxinA 195 U in medication overuse headache: a real-world experience A Negro, M Curto, L Lionetto, P Martelletti The Journal of Headache and Pain 17, 1-9, 2015 | 141 | 2015 |
| Neurocognition in schizophrenia: from prodrome to multi-episode illness V Corigliano, A De Carolis, G Trovini, J Dehning, S Di Pietro, M Curto, ... Psychiatry research 220 (1-2), 129-134, 2014 | 106 | 2014 |
| Xanthurenic acid activates mGlu2/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia F Fazio, L Lionetto, M Curto, L Iacovelli, M Cavallari, C Zappulla, ... Scientific reports 5 (1), 17799, 2015 | 105 | 2015 |
| Systematic review of clozapine cardiotoxicity M Curto, N Girardi, L Lionetto, GM Ciavarella, S Ferracuti, RJ Baldessarini Current Psychiatry Reports 18, 1-18, 2016 | 96 | 2016 |
| Altered kynurenine pathway metabolites in serum of chronic migraine patients M Curto, L Lionetto, A Negro, M Capi, F Fazio, MA Giamberardino, ... The Journal of Headache and pain 17, 1-7, 2016 | 88 | 2016 |
| Impact of migraine on fibromyalgia symptoms MA Giamberardino, G Affaitati, P Martelletti, C Tana, A Negro, D Lapenna, ... The journal of headache and pain 17, 1-9, 2016 | 88 | 2016 |
| Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study. L Lionetto, M Ulivieri, M Capi, D De Bernardini, F Fazio, A Petrucca, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1867 (3), 166042, 2021 | 81 | 2021 |
| OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study A Negro, M Curto, L Lionetto, D Crialesi, P Martelletti Springerplus 4, 1-8, 2015 | 79 | 2015 |
| Cinnabarinic acid and xanthurenic acid: Two kynurenine metabolites that interact with metabotropic glutamate receptors F Fazio, L Lionetto, M Curto, L Iacovelli, CS Copeland, SA Neale, V Bruno, ... Neuropharmacology 112, 365-372, 2017 | 78 | 2017 |
| Self-reported attenuated psychotic-like experiences in help-seeking adolescents and their association with age, functioning and psychopathology M Brandizzi, F Schultze-Lutter, A Masillo, A Lanna, M Curto, JF Lindau, ... Schizophrenia research 160 (1-3), 110-117, 2014 | 70 | 2014 |
| Altered serum levels of kynurenine metabolites in patients affected by cluster headache M Curto, L Lionetto, A Negro, M Capi, F Perugino, F Fazio, ... The Journal of Headache and Pain 17, 1-6, 2016 | 67 | 2016 |
| Executive functions in obsessive–compulsive disorder: An activation likelihood estimate meta-analysis of fMRI studies A Del Casale, C Rapinesi, GD Kotzalidis, P De Rossi, M Curto, D Janiri, ... The World Journal of Biological Psychiatry 17 (5), 378-393, 2016 | 59 | 2016 |
| Anti-CGRP monoclonal antibodies in migraine: current perspectives MA Giamberardino, G Affaitati, M Curto, A Negro, R Costantini, ... Internal and emergency medicine 11, 1045-1057, 2016 | 53 | 2016 |
| Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin … G Molinaro, A Traficante, B Riozzi, L Di Menna, M Curto, S Pallottino, ... Molecular pharmacology 76 (2), 379-387, 2009 | 50 | 2009 |
| Dialectical behaviour therapy (DBT) for forensic psychiatric patients: An Italian pilot study V Bianchini, V Cofini, M Curto, B Lagrotteria, A Manzi, S Navari, R Ortenzi, ... Criminal Behaviour and Mental Health 29 (2), 122-130, 2019 | 46 | 2019 |
| Lasmiditan for the treatment of migraine M Capi, F de Andrés, L Lionetto, G Gentile, F Cipolla, A Negro, M Borro, ... Expert opinion on investigational drugs 26 (2), 227-234, 2017 | 46 | 2017 |
| Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response M Capi, M Curto, L Lionetto, F De Andrés, G Gentile, A Negro, P Martelletti Therapeutic advances in neurological disorders 9 (5), 414-423, 2016 | 44 | 2016 |
| Antidepressant effectiveness of deep transcranial magnetic stimulation (dTMS) in patients with major depressive disorder (MDD) with or without alcohol use disorders (AUDs): a 6 … C Rapinesi, M Curto, GD Kotzalidis, A Del Casale, D Serata, VR Ferri, ... Journal of affective disorders 174, 57-63, 2015 | 44 | 2015 |
| Features preceding diagnosis of bipolar versus major depressive disorders G Serra, A Koukopoulos, L De Chiara, F Napoletano, AE Koukopoulos, ... Journal of Affective Disorders 173, 134-142, 2015 | 41 | 2015 |
